Kobuke, T <br/><br/>
A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma.  [electronic resource] 

 -  Digestive diseases and sciences  Sep 2006 
 - 1650-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0163-2116 
<br/><br/><label>Standard No.: </label>10.1007/s10620-005-9064-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Bile Duct Neoplasms--enzymology<br/>Bile Ducts, Intrahepatic--enzymology<br/>Caspase 3<br/>Caspase 9<br/>Caspases--metabolism<br/>Cell Culture Techniques<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cholangiocarcinoma--enzymology<br/>Chromans--pharmacology<br/>Humans<br/>Ligands<br/>Molecular Biology<br/>PPAR gamma--genetics<br/>Pioglitazone<br/>RNA, Neoplasm--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thiazolidinediones--pharmacology<br/>Troglitazone